Werkgroep Cardiologische centra Nederland

RED-HF (Completed)

Reduction of Events with Darbepoetin alfa in Heart Failure. A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Subjects With HF and Anemia.
Medicine
darbepo√ętine
Population
Heart failure
Phase
III
Starting year
2006
More information
ClinicalTrials.gov

Director of Study

dr. G.C.M. Linssen (Cardioloog)
Almelo, ZGT

RED-HF: News